You just read:

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

News provided by

Amira Pharmaceuticals, Inc.

May 11, 2011, 11:00 ET